Study finds biomarkers for psychiatric symptoms in patients with rare genetic condition 22q

A new UC Davis study finds biomarkers that could identify patients with 22q11.2 deletion syndrome who are more likely to develop schizophrenia.

Related Keywords

,Marwa Zafarullah ,Kathleen Angkustsiri ,Blythep Durbin Johnson ,Austin Quach ,Seungjn Yeo ,Heather Bowling ,Department Of Biochemistry ,Stanford University ,Dalton Bioanalytics Inc ,Uc Davis Health ,Flora Tassone ,Dalton Bioanalytics ,Newswise ,2q 11 2 Deletion Syndrome 22q Developmental Disabilities Biomarkers Psychosis Psychiatric Symptoms ,Uc Davis Mind Institute ,